Home › Aterosclerosi › Pennsylvania
Studi clinici su Aterosclerosi nello stato di Pennsylvania
11 studi su Aterosclerosi cercano partecipanti presso sedi nello stato di Pennsylvania.
Città nello stato di Pennsylvania
Testo ufficiale dello studio (inglese)
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Suburban Research Associates, West Chester
- Cardiology Consultants of Philadelphia Yardley, Yardley
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07783802A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
- Preferred Primary Care Physicians, Inc, Pittsburgh
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 29 set 2026 · NCT07448038Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- Lehigh Valley Health Network, Allentown
- Capital Area Research, LLC, Camp Hill
- Altoona Center For Clinical Research, Duncansville
- e altri 5
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 24 set 2026 · NCT07157774Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Heritage Valley Multispecialty Group Inc, Beaver
- Capital Area Research LLC, Camp Hill
- Abington Medical Specialists, Horsham
In reclutamentoFase 3
Età da 45 a 99 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07037433A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
- Capital Area Research, LLC - Camp Hill, Camp Hill
In reclutamentoFase 2
Età da 18 a 80 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07521007A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
- Heart and Vascular Research at WellSpan Health, York
In reclutamentoFase 3
Età da 45 a 80 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07613294Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Northeast Clinical Research Center, LLC, Bethlehem
- Clinical Renal Associates, LTD, Exton
In reclutamentoFase 2/3
Età 18 e oltre · Tutti i sessi · Aggiornato il 21 set 2026 · NCT05485961A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Camp Hill
- Research Site, Horsham
- Research Site, Philadelphia
- e altri 5
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 24 ago 2026 · NCT07000357Pelacarsen Roll-over Extension Program
- Care Access Research, Easton
- TCV Clinical Studies, Linwood
In reclutamentoFase 3
Età da 18 a 100 · Tutti i sessi · Aggiornato il 29 lug 2026 · NCT06875973MetfOrmin BenefIts Lower Extremities With Intermittent Claudication
- VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA, Pittsburgh
In reclutamentoFase 3
Età da 35 a 89 · Tutti i sessi · Aggiornato il 21 apr 2026 · NCT05132439How Animal and Plant Protein Shakes Change the Body's Nutrient and Health Responses
- UPMC Montefiore - Clinical and Translational Research Center (CTRC), Pittsburgh
In reclutamentoVolontari sani benvenuti
Età da 18 a 65 · Tutti i sessi · Aggiornato il 25 mar 2026 · NCT07121010Fonte: ClinicalTrials.gov, dati recuperati il 4 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.